- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pharmaceutical Representative Web Seminars
Pharmaceutical Representative is pleased is pleased to bring you informative, interactive, and cost-effective web seminars. These time-saving events are user friendly and designed to deliver information that will improve your bottom line. Please review the list below for upcoming topics.
We are pleased to bring you this informative, interactive, and cost-effective web seminar. This time-saving event is user friendly and designed to deliver information that will improve your bottom line.
Responding Proactively to Customer Questions About Industry Reputationwith Michael C. Pucci,Vice President of External Advocacy, GlaxoSmithKline
Date & Time: New Date Coming Soon!
Duration: 60 minutes
You Will Learn:
- Effective answers to questions about price
- The role of advertising in prevention and better treatment of disease
- How to demonstrate that the pharmaceutical industry cares about patients first
Click here to email and indicate your interest. We will get back to you with more information!
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
